Acotec Scientific Holdings Limited (6669.HK)
6669.HK Stock Price Chart
Explore Acotec Scientific Holdings Limited interactive price chart. Choose custom timeframes to analyze 6669.HK price movements and trends.
6669.HK Company Profile
Discover essential business fundamentals and corporate details for Acotec Scientific Holdings Limited (6669.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
24 Aug 2021
Employees
650.00
Website
https://www.acotec.cnCEO
Jing Li
Description
Acotec Scientific Holdings Limited, a medical device company, researches and develops percutaneous transluminal angioplasty and drug-coated balloon products for the treatment of vascular diseases in Mailand China, Europe, and internationally. It offers AcoArt Orchid & Dhalia to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease; under clinical studies in nephrology for arteriovenous fistula stenosis and in neurology for vertebral atherosclerotic stenosis indications/applications; and under clinical studies in andrology for vasculogenic erectile dysfunction indications/applications. The company also provides AcoArt Tulip & Litos, which is under registration process in China and Europe, and under preclinical studies in the United States in vascular surgery for below-the-knee artery disease indications/applications; and in pre-clinical studies in andrology for vasculogenic erectile dysfunction indications/applications. The company was incorporated in 2020 and is headquartered in Beijing, China. Acotec Scientific Holdings Limited is a subsidiary of CA Medtech Investment (Cayman) Limited.
6669.HK Financial Timeline
Browse a chronological timeline of Acotec Scientific Holdings Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 23 Mar 2025
EPS came in at $0.02 , while revenue for the quarter reached $133.70M .
Earnings released on 31 Dec 2024
EPS came in at $0.02 , while revenue for the quarter reached $128.53M .
Earnings released on 30 Aug 2024
EPS came in at $0.07 , while revenue for the quarter reached $156.97M .
Earnings released on 28 Jun 2024
EPS came in at $0.07 , while revenue for the quarter reached $158.14M .
Earnings released on 25 Mar 2024
EPS came in at -$0.01 , while revenue for the quarter reached $127.72M .
Earnings released on 23 Mar 2024
EPS came in at -$0.01 , while revenue for the quarter reached $123.77M .
Earnings released on 24 Aug 2023
EPS came in at $0.04 , while revenue for the quarter reached $138.73M .
Earnings released on 30 Jun 2023
EPS came in at $0.04 , while revenue for the quarter reached $131.43M .
Earnings released on 24 Mar 2023
EPS came in at $0.07 , while revenue for the quarter reached $120.96M .
Earnings released on 31 Dec 2022
EPS came in at $0.07 , while revenue for the quarter reached $125.41M .
Earnings released on 26 Aug 2022
EPS came in at $0.06 , while revenue for the quarter reached $102.62M .
Earnings released on 31 Mar 2022
EPS came in at $0.06 , while revenue for the quarter reached $108.03M .
Earnings released on 30 Mar 2022
EPS came in at -$0.15 , while revenue for the quarter reached $100.16M .
Earnings released on 29 Mar 2022
EPS came in at -$0.14 , while revenue for the quarter reached $98.67M .
Earnings released on 31 Aug 2021
EPS came in at $0.11 , while revenue for the quarter reached $104.31M .
Earnings released on 13 Aug 2021
EPS came in at -$0.15 , while revenue for the quarter reached $63.14M .
Earnings released on 31 Dec 2020
EPS came in at -$0.17 , while revenue for the quarter reached $74.77M .
Earnings released on 30 Sept 2020
EPS came in at -$0.17 , while revenue for the quarter reached $71.78M .
6669.HK Stock Performance
Access detailed 6669.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.